MARKET

RGEN

RGEN

Repligen
NASDAQ
144.60
+1.02
+0.71%
Opening 15:21 02/10 EST
OPEN
144.40
PREV CLOSE
143.58
HIGH
146.27
LOW
141.39
VOLUME
450.10K
TURNOVER
--
52 WEEK HIGH
175.77
52 WEEK LOW
102.97
MARKET CAP
8.14B
P/E (TTM)
5604.46
1D
5D
1M
3M
1Y
5Y
1D
Repligen Corporation to Announce Fourth Quarter and Full Year Financial Results
Reuters · 9h ago
Repligen Corporation kündigt Veröffentlichung von Finanzergebnissen an
Reuters · 9h ago
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
Barchart · 15h ago
Weekly Report: what happened at RGEN last week (0202-0206)?
Weekly Report · 1d ago
How Investors May Respond To Repligen (RGEN) Winning Backing For Its AI-Driven Bioprocessing Platform
Simply Wall St · 2d ago
Reassessing Repligen (RGEN) Valuation After Recent Share Price Weakness
Simply Wall St · 4d ago
Weekly Report: what happened at RGEN last week (0126-0130)?
Weekly Report · 02/02 10:11
Q/C Technologies Inc. Files Initial Beneficial Ownership Statement for Director Chelsea Sierra Voss
Reuters · 01/30 22:31
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.